UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)

BMC cancer, 2022-06, Vol.22 (1), p.604-604, Article 604

2022

Volltextzugriff (PDF)

"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians

Trials, 2023-02, Vol.24 (1), p.92-92, Article 92

2023

Volltextzugriff (PDF)

Drinking from the firehose – A clinician's perspective on the challenges of delivering biomarker-driven care in routine practice

European journal of cancer (1990), 2021-11, Vol.157, p.301-305

2021

Volltextzugriff (PDF)

Comment on Timing of Surgery For Patients With Rectal Cancers Not Responding to Preoperative Chemoradiation

JAMA surgery, 2022-06, Vol.157 (6), p.548

2022

Volltextzugriff (PDF)

Early Death After Chemotherapy as a Quality Indicator-Is It Time to Bench the Benchmark?

JAMA oncology, 2022-11, Vol.8 (11), p.1559

2022

Volltextzugriff (PDF)

Age alone is not a predictor for survival in glioblastoma

Journal of neuro-oncology, 2016-09, Vol.129 (3), p.479-485

2016

Volltextzugriff (PDF)

A systematic review of the impact of brain tumours on risk of motor vehicle crashes

Journal of neuro-oncology, 2024-02, Vol.166 (3), p.395-405

2024

Volltextzugriff (PDF)

Herpes zoster in patients with glioma treated with temozolomide

Journal of clinical neuroscience, 2024-11, Vol.129, p.110816, Article 110816

2024

Volltextzugriff (PDF)

Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?

JAMA oncology, 2021-08, Vol.7 (8), p.1246

2021

Volltextzugriff (PDF)

Long-term survivors of glioblastoma: a closer look

Journal of neuro-oncology, 2018, Vol.136 (1), p.155-162

2018

Volltextzugriff (PDF)

QLTI-04. LINKING DATA FROM A BRAIN CANCER CLINICAL REGISTRY (BRAIN) WITH THE STATE-BASED REGISTRY OF BIRTHS DEATHS MARRIAGES: IMPROVING THE QUALITY OF CLINICAL REGISTRY SURVIVAL DATA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v245-v245

2023

Volltextzugriff (PDF)

Cardiovascular disease and stroke following cancer and cancer treatment in older adults

Cancer, 2024-12, Vol.130 (23), p.4138-4148

2024

Volltextzugriff (PDF)

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Breast cancer research and treatment, 2023-02, Vol.198 (1), p.67-74

2023

Volltextzugriff (PDF)

Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13054-e13054

2023

Volltextzugriff (PDF)

Variable implementation of optimal therapeutic strategies in metastatic colorectal cancer: Reviewing rates of liver resection and triplet chemotherapy across Australian hospitals as potential quality indicators

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.248-248

2021

Volltextzugriff (PDF)

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

Acta oncologica, 2021-09, Vol.60 (9), p.1106-1113

2021

Volltextzugriff (PDF)

An Australian single institution experience in treating primary glioblastoma multiforme from 2010-2012

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e13043-e13043

2015

Volltextzugriff (PDF)

Impact of adjuvant chemotherapy and patient age on patterns of metastatic recurrence in stage III colorectal cancer

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.122-122

2021

Volltextzugriff (PDF)

Initial experience of TAS-102 chemotherapy in Australian patients with chemorefractory metastatic colorectal cancer

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.71-71

2021

Volltextzugriff (PDF)

Second primary cancers in patients with sporadic deficient mismatch repair (dMMR) colorectal cancer (CRC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.45-45

2021

Volltextzugriff (PDF)

Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry

Cancers, 2024-10, Vol.16 (20), p.3514

2024

Volltextzugriff (PDF)

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

Cancers, 2022-08, Vol.14 (17), p.4131

2022

Volltextzugriff (PDF)

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1038-1038

2020

Volltextzugriff (PDF)

CTNI-54. A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v88-v88

2023

Volltextzugriff (PDF)

EPID-10. LONG-TERM SURVIVORS OF GLIOBLASTOMA: A CLOSER LOOK

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi70-vi71

2017

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)

"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians

Drinking from the firehose – A clinician's perspective on the challenges of delivering biomarker-driven care in routine practice

Comment on Timing of Surgery For Patients With Rectal Cancers Not Responding to Preoperative Chemoradiation

Early Death After Chemotherapy as a Quality Indicator-Is It Time to Bench the Benchmark?

Age alone is not a predictor for survival in glioblastoma

A systematic review of the impact of brain tumours on risk of motor vehicle crashes

Herpes zoster in patients with glioma treated with temozolomide

Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?

Long-term survivors of glioblastoma: a closer look

QLTI-04. LINKING DATA FROM A BRAIN CANCER CLINICAL REGISTRY (BRAIN) WITH THE STATE-BASED REGISTRY OF BIRTHS DEATHS MARRIAGES: IMPROVING THE QUALITY OF CLINICAL REGISTRY SURVIVAL DATA

Cardiovascular disease and stroke following cancer and cancer treatment in older adults

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry

Variable implementation of optimal therapeutic strategies in metastatic colorectal cancer: Reviewing rates of liver resection and triplet chemotherapy across Australian hospitals as potential quality indicators

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

An Australian single institution experience in treating primary glioblastoma multiforme from 2010-2012

Impact of adjuvant chemotherapy and patient age on patterns of metastatic recurrence in stage III colorectal cancer

Initial experience of TAS-102 chemotherapy in Australian patients with chemorefractory metastatic colorectal cancer

Second primary cancers in patients with sporadic deficient mismatch repair (dMMR) colorectal cancer (CRC)

Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional Registry

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

CTNI-54. A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA

EPID-10. LONG-TERM SURVIVORS OF GLIOBLASTOMA: A CLOSER LOOK

Suchergebnisse filtern